Post by
Sokratesaes86 on Jan 09, 2022 10:36am
Inflarex Countdown to Party
Inflarex IFRX Germany course 3.80 Biopharma Further decision studies will be completed in the 1st half of 2022 including: Vilobelimab is not a Covid drug !!! It combats sepsis caused by Covid, and sepsis existed before Covid ... and will last long after Covid. Sepsis is one of the most common and cost-intensive diseases in the inpatient area. [1] The World Health Organization (WHO) declared the disease to be one of the leading priorities in the health systems of the member states in 2017 in order to improve the prevention, diagnosis, treatment, recording and follow-up of sepsis patients. Here's a billion dollar market if not so billiards. And Inflarex is on the verge of being the best drug with the fewest side effects. Just a few days!